🇺🇸 FDA
Pipeline program

ulodesine

BCX4208-203

Phase 2 small_molecule completed

Quick answer

ulodesine for Gout is a Phase 2 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
BIOCRYST PHARMACEUTICALS INC
Indication
Gout
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials